Realty Income Corp (O)
$62.35 1.72 (2.68%)
19:58 EDT O Stock Quote Delayed 30 Minutes
Previous Close $62.35
Market Cap 17.73B
PE Ratio 55.67
Volume (Avg. Vol.) 3.94M
Day's Range 62.27 - 63.90
52-Week Range 38.00 - 84.92
Dividend & Yield 2.63 (4.21%)
O Stock Predictions, Articles, and Realty Income Corp News
- From InvestorPlace
- From the Web
By Bob Ciura
Monthly dividend stocks pay out more frequently, which some investors prefer to quarterly payment. Here are 7 monthly dividend stocks to buy.
If you're looking for dependable income, these are 9 great monthly dividend stocks to buy for the regular payouts.
With interest rates reaching record lows, fixed income is no longer a reliable yield provider. These seven monthly dividend stocks could be a great alternative.
Realty Income stock is still down sharply from where it traded prior to the coronavirus. So are the shares worth picking up today?
Most dividend stocks pay out quarterly, which doesn’t necessarily suit our typical billing cycles. However, these eight companies offer payouts on a monthly basis.
Realty Income (O) earnings for the real estate investment company's first quarter of 2020 have O stock up after-hours Monday.
Finding safe dividend-yielding stocks that pay every month is tough. But these six monthly dividend stocks fit the bill.
These monthly dividend stocks represent a deep commitment to shareholders, using excellent cash flows to pay back investors.
Amazon, Boeing, Realty Income and Beyond Meat were our top stock trades to watch heading into Wednesday. Let's look at the charts.
Monday's broad market rally sets up three interesting stock charts for Tuesday's trading.
Coupa, Peloton, Canopy Growth, Realty Income and FedEx were our top stock trades from Tuesday. Here's a look at the charts.
These REITs all show significant promise ahead of their earnings reports this fall. Here's what makes these four names stand out among the rest.
These monthly dividend stocks give you dependable income month after month. Here are three excellent ones to consider.
In a topsy-turvy market, few investments look worthwhile. These high-yield REITs pay you to own them, no matter which way the market turns.
Income stocks are a great foundation for the good and not so good times.
Aimmune Therapeutics rallies on Nestle acquiring, Akcea cheers Ionis acquiring 24% remaining stake, ADiTx Therapeutics and Lipocine among major losers
Gainers: Aimmune Therapeutics (NASDAQ:AIMT) +172%, Akcea Therapeutics (NASDAQ:AKCA) +60%, Pro-Dex (NASDAQ:PDEX) +16%, Kindred Biosciences (NASDAQ:KIN) +14%, Neuronetics (NASDAQ:STIM) +11%.Losers: ADiTx Therapeutics (NASDAQ:ADTX) -11%, Lipocine (NASDAQ:LPCN) -11%, Orchard Therapeutics (NASDAQ:ORTX) -11%, CNS Pharmaceuticals (NASDAQ:CNSP) -9%, Anchiano Therapeutics (NASDAQ:ANCN) -8%.
Gainers: Equillium (NASDAQ:EQ) +220%.electroCore (NASDAQ:ECOR) +175%.WiMi Hologram Cloud (NASDAQ:WIMI) +73%.NovaBay Pharmaceuticals (NYSEMKT:NBY) +40%.Benefytt Technologies (NASDAQ:BFYT) +37%.OncoSec Medical (NASDAQ:ONCS) +37%.Vaxart (NASDAQ:VXRT) +37%.Lizhi (NASDAQ:LIZI) +35%.BiondVax Pharmaceuticals (NASDAQ:BVXV) +31%.Net Element (NASDAQ:NETE) +29%.Losers: Celsion (NASDAQ:CLSN) -63%.Gritstone Oncology (NASDAQ:GRTS) -50%.NextCure (NASDAQ:NXTC) -44%.Anchiano Therapeutics (NASDAQ:ANCN) -32%.Hermitage Offshore Services (NYSE:PSV) -30%.Senmiao Technology (NASDAQ:AIHS) -20%.Arcimoto (NASDAQ:FUV) -19%.Tarena International (NASDAQ:TEDU) -19%.iMedia Brands (NASDAQ:IMBI) -16%.BlueCity Holdings (NASDAQ:BLCT) -16%.
Navellier RatingsPowered by Portfolio Grader